Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Get essential year-end tax filing guidance for DRIP ETFs, including records to gather and strategies to reduce liabilities.
24,400 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A Nashville couple with a newborn faces $189,000 in debt as rising interest costs squeeze monthly budgets. Experts ur...
AARP launches its largest Community Challenge round yet, awarding $8.3 million to fund 750 projects that upgrade hous...
Walmart announced a $1.4 billion purchase of Vibe.co, a French ad-tech company. The move expands Walmart Connect into...
The S&P 500 closed near a decisive support level, raising the specter of additional losses if buyers fail to defend. ...
The idea of spacex worth $1.77 trillion has investors buzzing, but profitability is the real test. This article offer...
As markets wobble and political headwinds rise, a growing chorus argues that ceos have forgotten moderate. This piece...
Applied Digital signals a slower AI data-center buildout through 2027 amid labor constraints, with hyperscalers pushi...
A bipartisan push in Congress seeks a federal registry for trusted AI agents and a fiduciary standard for robo-adviso...
Salesforce stock today has been in the spotlight as investors weigh new AI advancements against business execution. T...
Three leading egg producers settle with federal and state regulators over alleged price‑fixing, donating 53 million e...
Investors are turning away from Hewlett Packard Enterprise as a dividend-rich tech giant with a clearer AI roadmap ga...